Advertisement
Screener

Biofrontera Inc. (BFRI) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Biofrontera Inc. Cash Flow Breakdown

Cash flow breakdown shows where Biofrontera Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $13.36M went out.
  • Fiscal year ended 2025-12-31: from investing, $3.00M came in.
  • Fiscal year ended 2025-12-31: from financing, $10.85M came in.
  • Fiscal year ended 2025-12-31: change in cash, $487.00K came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingCommercial paperNew shares soldNot split outChange in cash
2025-12-31-$13.36M$3.00M$10.85M*$487.00K
2024-12-31-$10.27M-$3.00K$14.84M*$4.56M
2023-12-31-$24.89M$619.00K$21.45M$4.51M-$17.54M*-$15.87M
2022-12-31-$16.20M-$5.16M$14.02M*-$7.33M
2021-12-31-$26.71M-$11.00K$14.94M$28.25M*$16.46M
2020-12-31-$12.37M$13.19M*$825.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingCommercial paperNot split outChange in cash
2026-06-30-$1.66M*$0.00*
2026-03-31-$70.00K-$5.00K-$75.00K
2025-12-31-$2.38M*$3.00M*$2.35M*
2025-09-30-$3.82M*$1.00K*
2025-06-30-$3.04M*-$1.00K*
2025-03-31-$4.12M-$3.00K-$4.12M
2024-12-31-$1.02M*-$1.00K*$4.05M*
2024-09-30-$1.21M*$0.00*$0.00*
2024-06-30-$4.72M*$0.00*$5.28M*
2024-03-31-$3.33M-$357.00K$6.16M*$2.47M
2023-12-31-$8.87M*$73.00K*$7.90M*-$1.19M*
2023-09-30-$2.00M*$382.00K*$591.00K*
2023-06-30-$10.34M*$178.00K*
2023-03-31-$3.69M-$14.00K-$3.70M
2022-12-31-$8.27M*-$2.09M*
2022-09-30-$5.94M*-$3.03M*$4.63M*
2022-06-30$125.00K*-$31.00K*
2022-03-31-$2.11M-$5.00K-$2.12M
2021-12-31-$20.99M*-$9.00K*$43.83M*
2021-09-30-$1.22M*$1.00K*
2021-06-30-$1.06M*
2021-03-31-$3.44M-$3.44M
2020-12-31-$663.00K*$4.34M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Cellectar Biosciences, Inc. (CLRB)United States$0.020B-1.03
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Korsana Biosciences, Inc. (CYCN)United States$0.016B